Unbiased Analysis of Today's Healthcare Issues

Archive for the 'Current Events' Category

The Healthcare Economist on NPR

Check out my interview on NPR with Here & Now’s Jeremy Hobson about what recent changes in health insurance premiums changes mean for the future of the Affordable Care Act.  

Read the rest of this entry »

Friday Links

Rising drug prices. QPP. Healthcare-wide CER. The age of tech. AI and medicine.

Read the rest of this entry »

Obamacare Death Spiral?

Health insurance premiums are projected to increase an astronomical 25% for plans in the health insurance exchanges. Some pundits claim that these increases represent that Obamacare is crumbling or in a death spiral. As premiums rise, healthy people flee the market. This leaves insurers with only more sick individuals which leads to premium increases. More […]

Read the rest of this entry »

Friday Links

Should prisoners get a cure for HCV? Food stamps and beer. Cutting a cake fairly. Uber for caregivers. MSF rejects 1m free vaccines.

Read the rest of this entry »

Friday Links

Health state utilities: Best practices and critique. Health, big data and privacy. Tying drug prices to patient outcomes. Dr. Watson. Absolute vs. relative risk.

Read the rest of this entry »

2016 Nobel Prize in Medicine goes to…

Yoshinori Ohsumi. He won the award for his discoveries of mechanisms for autophagy. What is autophagy? The Nobel Prize website explains: The word autophagy originates from the Greek words auto-, meaning “self”, and phagein, meaning “to eat”. Thus,autophagy denotes “self eating”. This concept emerged during the 1960’s, when researchers first observed that the cell could […]

Read the rest of this entry »

2016 Nobel Prize in Economics goes to…

…Oliver Hart and Bengt Holmström for their research on contract theory. One of my favorite papers in all of economics is Holmstrom and Milgrom’s 1991 paper titled “Multitask Principal-Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design.”  In a world where health care is increasingly moving to value-based payment, payers (i.e., insurance companies, employers, and the government) are increasingly […]

Read the rest of this entry »

Friday Links

The for-profit charity? The reliability of Chinese RCT data. 122. Hackable insulin pumps? Nano cars

Read the rest of this entry »

China fabricates clinical trial data?

Academic integrity is one of the bedrocks upon which research is founded.  With that said, it is with great concern that I came across an article that stated that 80% of Chinese clinical trials data is fabricated.  Science Alert reports: The review looked at data from 1,622 clinical trial programs of new pharmaceutical drugs awaiting regulator approval for mass […]

Read the rest of this entry »

Friday Links

Using biomarker data. Cancer moonshot has started. Frakt on value frameworks. A downside of work. Drug price negotiation coming to the U.S.

Read the rest of this entry »